Skip to content
Monday, May 4, 2026
Canada's Leading Online Business Magazine
X-twitter
Search
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
×
Home
CBJ Newsmakers
Business in Action
Features
CBJ News
Home
CBJ Newsmakers
Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
CBJ Newsmakers
Recommended
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
Cognitrex Inc. Announces Market Entry of Enterprise LearningOS Platform Led by Founder Hana Dhanji
Bombardier to Provide Six Multi-role Aircraft to Support the Royal Canadian Air Force
